iShares Russell 2000 ETF Newsroom

Buy Rating Affirmed for Insmed on Breakthrough Trials and Market Expansion Opportunities

TipRanksAug 13 10:09 ET

J.P. Morgan Maintains Fabrinet(FN.US) With Hold Rating, Raises Target Price to $240

Moomoo NewsAug 13 06:35 ET

Fabrinet Analyst Ratings

BenzingaAug 12 14:47 ET

JP Morgan Maintains Neutral on Fabrinet, Raises Price Target to $240

BenzingaAug 12 14:47 ET

Insmed Analyst Ratings

BenzingaAug 12 07:34 ET

Truist Financial Reaffirms Their Buy Rating on Insmed (INSM)

TipRanksAug 12 07:32 ET

Brensocatib Poised for Market Success: A Buy Rating for Insmed Amid Positive KOL Sentiment and Limited Competition

TipRanksAug 12 06:37 ET

Insmed (INSM) Receives a Buy From Morgan Stanley

TipRanksAug 9 09:48 ET

Insmed Analyst Ratings

BenzingaAug 9 08:38 ET

Insmed's Promising Outlook: Buy Rating Backed by Arikayce Performance and Brenso Launch Potential

TipRanksAug 9 07:31 ET

Strong Arikayce Sales and Promising Clinical Advancements Bolster Buy Rating for Insmed

TipRanksAug 8 21:37 ET

Analysts Offer Insights on Industrial Goods Companies: Rockwell Automation (ROK), FTAI Aviation (FTAI) and AerSale Corporation (ASLE)

TipRanksAug 8 08:00 ET

Morgan Stanley Lowers Price Target on Abercrombie & Fitch to $155 From $172, Keeps Equalweight Rating

MT NewswiresAug 7 07:38 ET

Buy Rating Affirmed for Vaxcyte Ahead of Key VAX-31 Phase 1/2 Milestone

TipRanksAug 7 05:47 ET

Vaxcyte Analyst Ratings

BenzingaAug 7 05:43 ET

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating

Moomoo NewsAug 6 20:32 ET

Optimistic Buy Rating for Vaxcyte Amidst Promising Vaccine Candidate Progress and Strategic Positioning

TipRanksAug 6 19:50 ET

Fluor Analyst Ratings

BenzingaAug 6 11:31 ET

Ensign Energy Services (ESI) Gets a Hold From CIBC

TipRanksAug 6 10:14 ET

DA Davidson Maintains Buy on Fluor, Raises Price Target to $58

BenzingaAug 5 18:48 ET